Total Payments
$17,968
2024 Payments
$2,303
Companies
66
Transactions
1,259
Medicare Patients
18,712
Medicare Billing
$889,226
Payment Breakdown by Category
Food & Beverage$17,810 (99.1%)
Education$158.55 (0.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $17,810 | 1,250 | 99.1% |
| Education | $158.55 | 9 | 0.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,950 | 142 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,801 | 102 | $0 (2024) |
| Amgen Inc. | $1,533 | 100 | $0 (2024) |
| ABBVIE INC. | $1,513 | 120 | $0 (2024) |
| Lilly USA, LLC | $919.47 | 99 | $0 (2024) |
| PFIZER INC. | $772.17 | 52 | $0 (2024) |
| Amarin Pharma Inc. | $735.89 | 53 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $669.67 | 42 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $660.59 | 39 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $655.08 | 64 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,303 | 141 | Amgen Inc. ($425.14) |
| 2023 | $2,150 | 155 | ABBVIE INC. ($384.02) |
| 2022 | $2,478 | 181 | ABBVIE INC. ($408.10) |
| 2021 | $2,881 | 202 | Novo Nordisk Inc ($291.49) |
| 2020 | $2,248 | 141 | AstraZeneca Pharmaceuticals LP ($452.50) |
| 2019 | $1,773 | 134 | AstraZeneca Pharmaceuticals LP ($189.97) |
| 2018 | $1,637 | 116 | AstraZeneca Pharmaceuticals LP ($240.21) |
| 2017 | $2,500 | 189 | AstraZeneca Pharmaceuticals LP ($312.31) |
All Payment Transactions
1,259 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $6.31 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Gastroenterology | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Gastroenterology | ||||||
| 12/09/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $11.84 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $27.07 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.15 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $12.24 | General |
| Category: PAIN | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: PAIN | ||||||
| 11/27/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: PAIN | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/19/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $12.95 | General |
| Category: Bone Health | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: UROLOGY | ||||||
| 11/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.22 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.09 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $1.14 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Inflammation | ||||||
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $5.37 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.27 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $1.42 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.12 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $28.88 | General |
| Category: Cardio-renal | ||||||
| 10/22/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Bone Health | ||||||
| 10/21/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $19.97 | General |
| Category: UROLOGY | ||||||
| 10/18/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: PAIN | ||||||
| 10/16/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Obesity | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 40 | 3,139 | 4,410 | $338,102 | $118,284 |
| 2022 | 55 | 5,596 | 8,990 | $710,144 | $282,991 |
| 2021 | 53 | 5,640 | 9,199 | $709,778 | $284,046 |
| 2020 | 39 | 4,337 | 6,953 | $564,671 | $203,905 |
Total Patients
18,712
Total Services
29,552
Medicare Billing
$889,226
Procedure Codes
187
All Medicare Procedures & Services
187 procedure records from CMS Medicare Utilization — Page 1 of 8
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 249 | 411 | $100,902 | $34,680 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 277 | 443 | $74,752 | $25,958 | 34.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 125 | 125 | $33,721 | $15,448 | 45.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 240 | 350 | $12,065 | $4,580 | 38.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 272 | 417 | $12,670 | $4,307 | 34.0% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 54 | 54 | $9,270 | $3,879 | 41.8% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 282 | 427 | $9,997 | $3,243 | 32.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 256 | 383 | $4,935 | $3,209 | 65.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 202 | 293 | $11,700 | $2,781 | 23.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 35 | 37 | $3,540 | $2,609 | 73.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 45 | 46 | $3,762 | $1,664 | 44.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 24 | 40 | $3,040 | $1,596 | 52.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 88 | 155 | $6,545 | $1,520 | 23.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 49 | 51 | $2,510 | $1,505 | 60.0% |
| 83721 | Ldl cholesterol level | Office | 2023 | 129 | 137 | $10,960 | $1,410 | 12.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 70 | 70 | $2,746 | $1,231 | 44.8% |
| 99442 | Telephone medical discussion with physician, 11-20 minutes | Office | 2023 | 19 | 22 | $4,014 | $1,089 | 27.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 53 | 53 | $2,120 | $932.27 | 44.0% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 11 | 29 | $2,497 | $911.76 | 36.5% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 39 | 41 | $2,616 | $745.01 | 28.5% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 154 | 177 | $3,186 | $550.47 | 17.3% |
| 99441 | Telephone medical discussion with physician, 5-10 minutes | Office | 2023 | 22 | 24 | $2,667 | $521.88 | 19.6% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 18 | 32 | $1,230 | $519.04 | 42.2% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 14 | 14 | $1,050 | $468.86 | 44.7% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 13 | 13 | $1,125 | $450.06 | 40.0% |
About Dr. Samuel Ramirez, MD
Dr. Samuel Ramirez, MD is a Family Medicine healthcare provider based in Mcallen, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538190244.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Ramirez, MD has received a total of $17,968 in payments from pharmaceutical and medical device companies, with $2,303 received in 2024. These payments were reported across 1,259 transactions from 66 companies. The most common payment nature is "Food and Beverage" ($17,810).
As a Medicare-enrolled provider, Ramirez has provided services to 18,712 Medicare beneficiaries, totaling 29,552 services with total Medicare billing of $889,226. Data is available for 4 years (2020–2023), covering 187 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Mcallen, TX
- Active Since 07/05/2006
- Last Updated 06/28/2010
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1538190244
Products in Payments
- FARXIGA (Drug) $1,458
- Ozempic (Drug) $878.71
- Vascepa (Drug) $735.89
- NURTEC ODT (Drug) $730.81
- VRAYLAR (Drug) $729.55
- EVENITY (Biological) $542.26
- Otezla (Drug) $400.74
- JARDIANCE (Drug) $391.84
- TRULICITY (Drug) $382.64
- LINZESS (Drug) $351.20
- TRULANCE (Drug) $345.58
- Rybelsus (Drug) $342.59
- XIFAXAN (Drug) $336.00
- TRADJENTA (Drug) $319.75
- JANUVIA (Drug) $317.36
- ELIQUIS (Drug) $296.67
- UBRELVY (Drug) $290.56
- TOUJEO (Drug) $279.06
- Linzess (Drug) $249.67
- Prolia (Biological) $226.52
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Mcallen
Enrique Griego, M.d, M.D
Family Medicine — Payments: $265,383
Family Medicine $265,383
Roman Tavarez, Md, MD
Family Medicine — Payments: $55,953
Family Medicine $55,953
Dr. Donna Joule, Md, MD
Family Medicine — Payments: $29,327
Family Medicine $29,327
Noel Lopez, M.d, M.D
Family Medicine — Payments: $15,145
Family Medicine $15,145
Dr. Samuel Garcia, M. D, M. D
Family Medicine — Payments: $11,698
Family Medicine $11,698
Jose Rodriguez, Md, MD
Family Medicine — Payments: $7,782
Family Medicine $7,782